Highlights from this issue
Mental health in cystic fibrosis
What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?
Interstitial lung disease
β-Blockers are associated with a reduction in COPD exacerbations
Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD
International Committee on Mental Health in Cystic Fibrosis
Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals
Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT
Phosphoinositide 3-kinase-δ regulates fungus-induced allergic lung inflammation through endoplasmic reticulum stress
Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases
The molecular targets of approved treatments for pulmonary arterial hypertension
Underweight as a risk factor for respiratory death in the Whitehall cohort study
Handgrip weakness and mortality risk in COPD
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
Research in progress—LungSEARCH
An incidental pulmonary part-solid ground-glass nodule in a patient under anticoagulant therapy
Pulmonary metastasised extraskeletal osteosarcoma
18F-Misonidazole PET-CT scan detection of occult bone metastasis
What’s hot that the other lot got